🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Dapagliflozin is a highly selective, reversible and potent inhibitor of the...
Status
Completed
Location
Medical University Innsbruck, Department of Internal Medicine I
Start Date
2014-08
Trial ID
NCT02211742
Treatments Being Tested
To assess whether the addition of dapagliflozin to semaglutide and insulin ...
Status
Active Not Recruiting
Location
Diabetes and Endocrinology Research Center of WNY
Start Date
2019-05-01
Trial ID
NCT03899402
Treatments Being Tested
The goal of this clinical trial is to examine the effectiveness of a drug n...
Status
Active Not Recruiting
Location
Bawsher Health Center
Start Date
2024-04-22
Trial ID
NCT06000462
Treatments Being Tested
Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated cardiov...
Status
Unknown
Location
Yonsei University Wonju College of Medicine
Start Date
2022-01-07
Trial ID
NCT05194592
Treatments Being Tested
Trial Design: This is a 12 week randomised controlled open label trial comp...
Status
Unknown
Location
Tan Tock Seng Hospital
Start Date
2019-04-01
Trial ID
NCT05440591
Treatments Being Tested
The purpose of this research study is to learn about the effect of Dapaglif...
Status
Completed
Location
University of Miami
Start Date
2015-09
Trial ID
NCT02235298
Treatments Being Tested
In this observational study, 60 subjects with type 2 diabetes (T2D) and eli...
Status
Completed
Location
University of Pisa
Start Date
2020-10-07
Trial ID
NCT04735042
The ATTEMPT (Adolescent Type 1 diabetes Treatment with SGLT2i for hyperglyc...
Status
Active Not Recruiting
Location
Children's Hospital Colorado Anschutz Medical Campus
Start Date
2020-12-11
Trial ID
NCT04333823
Treatments Being Tested
Diabetes mellitus is a progressive endocrine disease characterized by insul...
Status
Completed
Location
Endocrine and Diabetes Center
Start Date
2024-12-01
Trial ID
NCT06719661
Treatments Being Tested
To assess the effect of sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...
Status
Completed
Location
Tulane University
Start Date
2016-03
Trial ID
NCT02796170
Treatments Being Tested